Monitoring of Immune Response Following Covid-19 Vaccination

Introduction: SARS-CoV-2 is an infectious, viral, and contagious disease in which most patients present a mild respiratory condition whose recovery is autonomous and guided by the immune system itself. Objectives: The objectives of this research were to evaluate the immune system, the vaccination doses administered to the inhabitants of the parish of El Recreo, located in the Duran Canton of the Province of Guayas (Ecuador), according to age groups and gender, the vaccination coverage and the incidence of new diseases in the population under study. Material and Methods: This was a descriptive, non-experimental, prospective, cross-sectional, field study. It was carried out during the period from November 2021 to March 2022, during the pandemic of the "Omicron" variant. Results: the predominant age group corresponded to the range of 50-59 years (26.83% and 42; 29.79%) for both genders. We found (90.10%) of the population vaccinated. Another group (3.31%) did not receive the biologic and (6.59%) indicated that they were reluctant to receive the product. The second dose was administered to (83.5%) people in the community, while (14.28%) indicated having received the third dose. (3.04%) became ill after receiving the first doses; (2.63%) the second doses and none of those who received the third doses. It is necessary to alert the population of the need to benefit from the application of the vaccine since it seems to confer a certain degree of protection to the inhabitants and thus, the viral spread, hospitalization and death.